Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index.

PubWeight™: 1.55‹?› | Rank: Top 4%

🔗 View Article (PMID 12527956)

Published in Support Care Cancer on August 21, 2002

Authors

Declan Walsh1, Fade Mahmoud, Barbara Barna

Author Affiliations

1: The Harry R Horvitz Center for Palliative Medicine, Cleveland, Ohio, USA. walsht@ccf.org

Articles citing this

C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One (2015) 1.03

Measurement of nutrition status in Crohn's disease patients receiving infliximab therapy. Nutr Clin Pract (2008) 0.90

Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors. Thorac Cancer (2015) 0.80

Protein calorie malnutrition, nutritional intervention and personalized cancer care. Oncotarget (2017) 0.80

Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value. Support Care Cancer (2016) 0.79

Proposal for a recovery prediction method for patients affected by acute mediastinitis. World J Emerg Surg (2012) 0.77

Evaluation of recovery in iatrogenic evoked acute mediatinitis. Inflammation (2013) 0.75

Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index. By Declan Walsh et al. Supportive Care in Cancer (2003) 11:60-62. Support Care Cancer (2003) 0.75

Wheel Balanced Cancer Therapy for Longer Than 21 Days Can Have a Positive Effect on the Survival of Patients with Stage IV Cancer. J Pharmacopuncture (2015) 0.75

Orosomucoid is an independent predictor of prognosis in chronic heart failure. Wien Klin Wochenschr (2016) 0.75